| CSX (N = 92) | CAD (N = 145) | p |
---|---|---|---|
Age (years) | 59 ± 11 | 62 ± 13 | 0.015 |
Gender (M/F) | 62/30 | 132/13 | <0.001 |
Hypertension (N) (%) | 71 (77%) | 134 (92%) | 0.002 |
Systolic blood pressure (mmHg) | 125 (114, 135) | 128 (117, 141) | 0.049 |
Body mass index (kg/m2) | 25.0 (23.9, 27.3) | 25.9 (23.7, 28.2) | 0.174 |
Current smoking (N) (%) | 51 (55%) | 86 (60%) | 0.563 |
Total cholesterol (mg/dl) | 185 (165, 209) | 165 (143, 193) | <0.001 |
LDL-C (mg/dl) | 107 (91, 122) | 90 (74, 112) | <0.001 |
HDL-C (mg/dl) | 48 (43, 58) | 43 (38, 51) | <0.001 |
Triglycerides (mg/dl) | 122 (88, 173) | 118 (88, 164) | 0.960 |
Adiponectin (μg/ml) | 3.7 (1.5, 6.0) | 3.6 (1.5, 5.8) | 0.583 |
Leptin (ng/ml) | 4.2 (2.3, 8.5) | 4.5 (2.8, 8.3) | 0.627 |
Hs-CRP (mg/dl) | 0.09 (0.02, 0.25) | 0.12 (0.05, 0.26) | 0.104 |
Medication before index admission | |||
Use of statin (N) (%) | 13 (14%) | 56 (39%) | <0.001 |
Use of fibrates (N) (%) | 2 (2%) | 1 (0.7%) | 0.689 |
Use of anti-hypertensive medication (N) (%) | 71 (77%) | 134 (92%) | 0.002 |
Medication post index admission | Â | Â | Â |
Use of statin (N) (%) | 22 (24%) | 100 (69%) | <0.001 |